HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Transverse endoplasmic reticulum expansion in hereditary spastic paraplegia corticospinal axons.

Abstract
Hereditary spastic paraplegias (HSPs) comprise a large group of inherited neurologic disorders affecting the longest corticospinal axons (SPG1-86 plus others), with shared manifestations of lower extremity spasticity and gait impairment. Common autosomal dominant HSPs are caused by mutations in genes encoding the microtubule-severing ATPase spastin (SPAST; SPG4), the membrane-bound GTPase atlastin-1 (ATL1; SPG3A) and the reticulon-like, microtubule-binding protein REEP1 (REEP1; SPG31). These proteins bind one another and function in shaping the tubular endoplasmic reticulum (ER) network. Typically, mouse models of HSPs have mild, later onset phenotypes, possibly reflecting far shorter lengths of their corticospinal axons relative to humans. Here, we have generated a robust, double mutant mouse model of HSP in which atlastin-1 is genetically modified with a K80A knock-in (KI) missense change that abolishes its GTPase activity, whereas its binding partner Reep1 is knocked out. Atl1KI/KI/Reep1-/- mice exhibit early onset and rapidly progressive declines in several motor function tests. Also, ER in mutant corticospinal axons dramatically expands transversely and periodically in a mutation dosage-dependent manner to create a ladder-like appearance, on the basis of reconstructions of focused ion beam-scanning electron microscopy datasets using machine learning-based auto-segmentation. In lockstep with changes in ER morphology, axonal mitochondria are fragmented and proportions of hypophosphorylated neurofilament H and M subunits are dramatically increased in Atl1KI/KI/Reep1-/- spinal cord. Co-occurrence of these findings links ER morphology changes to alterations in mitochondrial morphology and cytoskeletal organization. Atl1KI/KI/Reep1-/- mice represent an early onset rodent HSP model with robust behavioral and cellular readouts for testing novel therapies.
AuthorsPeng-Peng Zhu, Hui-Fang Hung, Natalia Batchenkova, Jonathon Nixon-Abell, James Henderson, Pengli Zheng, Benoit Renvoisé, Song Pang, C Shan Xu, Stephan Saalfeld, Jan Funke, Yuxiang Xie, Fabian Svara, Harald F Hess, Craig Blackstone
JournalHuman molecular genetics (Hum Mol Genet) Vol. 31 Issue 16 Pg. 2779-2795 (08 23 2022) ISSN: 1460-2083 [Electronic] England
PMID35348668 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Intramural)
Copyright© The Author(s) 2022. Published by Oxford University Press. All rights reserved. For Permissions, please email: [email protected].
Chemical References
  • Membrane Proteins
  • Membrane Transport Proteins
  • atlastin-1 protein, mouse
  • GTP Phosphohydrolases
  • Spastin
Topics
  • Animals
  • Axons (metabolism)
  • Disease Models, Animal
  • Endoplasmic Reticulum (genetics, metabolism)
  • GTP Phosphohydrolases (genetics)
  • Humans
  • Membrane Proteins (genetics)
  • Membrane Transport Proteins (genetics)
  • Mice
  • Mice, Knockout
  • Mutation
  • Spastic Paraplegia, Hereditary (genetics)
  • Spastin (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: